Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aguirre, K., Havell, E.A., Gibson, G.W., and Johnson, L.L. (1995). Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun. 63(5): 1725–1731.
Almeida, G.M., Andrade, R.M., and Bento, C.A. (2001). The capsular polysaccharides of Cryptococcus neoformans activate normal CD4(+) T cells in a dominant Th2 pattern. J. Immunol. 167(10): 5845–5851.
Arora, S., Hernandez, Y.H., Erb-Downward, J.R., McDonald, R.A., Toews, G.B., and Huffnagle, G.B. (2005a). Role of IFN-γ in regulating T2 immunity and the development of alternatively activated macrophages during Cryptococcus neoformans infection. J. Immunol. (in press).
Bauman, S.K., Huffnagle, G.B., and Murphy, J.W. (2003). Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response. Infect. Immun. 71(1): 68–74.
Baumgarth, N. and Kelso, A. (1996). Functionally distinct T cells in three compartments of the respiratory tract after influenza virus infection. Eur. J. Immunol. 26(9): 2189–2197.
Bennett, S.R., Carbone, F.R., Karamalis, F., Flavell, R.A., Miller, J.F., and Heath, W.R. (1998). Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393(6684): 478–480.
Betz, M. and Fox, B.S. (1991). Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146(1): 108–113.
Biondo, C., Beninati, C., Delfino, D., Oggioni, M., Mancuso, G., Midiri, A., Bombaci, M., Tomaselli, G., and Teti, G. (2002). Identification and cloning of a cryptococcal deacetylase that produces protective immune responses. Infect. Immun. 70(5): 2383–2391.
Blackstock, R. and Murphy, J.W. (2004). Role of interleukin-4 in resistance to Cryptococcus neoformans infection. Am. J. Respir. Cell Mol. Biol. 30(1): 109–117.
Buchanan, K.L. and Murphy, J.W. (1998). What makes Cryptococcus neoformans a pathogen? Emerg. Infect. Dis. 4(1): 71–83.
Chen, G.H., Curtis, J.L., Mody, C.H., Christensen, P.J., Armstrong, L.R., and Toews, G.B. (1994). Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. J. Immunol. 152(2): 724–734.
Chiapello, L.S., Aoki, M.P., Rubinstein, H.R., and Masih, D.T. (2003). Apoptosis induction by glucuronoxylomannan of Cryptococcus neoformans. Med. Mycol. 41(4): 347–353.
Chiller, T., Farrokhshad, K., Brummer, E., and Stevens, D.A. (2002). Effect of granulocyte colony-stimulating factor and granulocytemacrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans. Med. Mycol. 40(1): 21–26.
Collins, H.L. and Bancroft, G.J. (1991). Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses. Infect. Immun. 59(11): 3883–3888.
Collins, H.L. and Bancroft, G.J. (1992). Cytokine enhancement of complement-dependent phagocytosis by macrophages: Synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur. J. Immunol. 22(6): 1447–1454.
Curtis, J.L., Huffnagle, G.B., Chen, G.H., Warnock, M.L., Gyetko, M.R., McDonald, R.A., Scott, P.J., and Toews, G.B. (1994). Experimental murine pulmonary cryptococcosis. Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans. Lab. Invest. 71(1): 113–126.
Decken, K., Kohler, G., Palmer-Lehmann, K., Wunderlin, F., Mattner, F., Magram, J., Gately, M.K., and Alber, G. (1998). Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun. 66(10): 4994–5000.
Dong, Z.M. and Murphy, J.W. (1993). Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen. Infect. Immun. 61(12): 5067–5077.
Dong, Z.M. and Murphy, J.W. (1995). Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation. Infect. Immun. 63(3): 770–778.
Dong, Z.M., Jackson, L., and Murphy, J.W. (1999). Mechanisms for induction of L-selectin loss from T lymphocytes by a cryptococcal polysaccharide, glucuronoxylomannan. Infect. Immun. 67(1): 220–229.
Fries, B.C., Taborda, C.P., Serfass, E., and Casadevall, A. (2001). Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J. Clin. Invest. 108(11): 1639–1648.
Furukawa, K., Kobayashi, M., Sasaki, H., Herndon, D.N., Pollard, R.B., and Suzuki, F. (2002). Cryptococcal encephalitis in thermally injured mice is accelerated by type 2 T-cell responses. Crit. Care Med. 30(7): 1419–1424.
Goerdt, S. and Orfanos, C.E. (1999). Other functions, other genes: Alternative activation of antigen-presenting cells. Immunity 10(2): 137–142.
Goldman, D.L., Fries, B.C., Franzot, S.P., Montella, L., and Casadevall, A. (1998). Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents. Proc. Natl. Acad. Sci. USA 95(25): 14967–14972.
Hamilton, J.R., Noble, A., Denning, D.W., and Stevens, D.A. (1991). Performance of Cryptococcus antigen latex agglutination kits on serum and cerebrospinal fluid specimens of AIDS patients before and after pronase treatment. J. Clin. Microbiol. 29(2): 333–339.
Harrison, T.S., Kornfeld, H., and Levitz, S.M. (1995). The effect of infection with human immunodeficiency virus on the anticryptococcal activity of lymphocytes and monocytes. J. Infect. Dis. 172(3): 665–671.
Hernandez, Y.H., Erb-Downward, J.R., McDonald, R.A., Toews, G.B., and Huffnagle, G.B. (2005a). Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J. Immunol. 174(2): 1027–1036.
Herring, A.C., Lee, J., McDonald, R.A., Toews, G.B., and Huffnagle, G.B. (2002). Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. Infect. Immun. 70(6): 2959–2964.
Hill, J.O. and Harmsen, A.G. (1991). Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells. J. Exp. Med. 173(3): 755–758.
Hoag, K.A., Lipscomb, M.F., Izzo, A.A., and Street, N.E. (1997). IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am. J. Respir. Cell Mol. Biol. 17(6): 733–739.
Honda, K., Arima, M., Cheng, G., Taki, S., Hirata, H., Eda, F., Fukushima, F., Yamaguchi, B., Hatano, M., Tokuhisa, T., and Fukuda, T. (2003). Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. J. Exp. Med. 198(4): 533–543.
Howard, A.D. and Zwilling, B.S. (1998). Cytokine production by CD4 and CD8 T cells during the growth of Mycobacterium tuberculosis in mice. Clin. Exp. Immunol. 113(3): 443–449.
Hoy, J.F., Lewis, D.E., and Miller, G.G. (1988). Functional versus phenotypic analysis of T cells in subjects seropositive for the human immunodeficiency virus: A prospective study of in vitro responses to Cryptococcus neoformans. J. Infect. Dis. 158(5): 1071–1078.
Hoy, J.F., Murphy, J.W., and Miller, G.G. (1989). T cell response to soluble cryptococcal antigens after recovery from cryptococcal infection. J. Infect. Dis. 159(1): 116–119.
Huang, C., Nong, S.H., Mansour, M.K., Specht, C.A., and Levitz, S.M. (2002). Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-cell responses. Infect. Immun. 70(10): 5485–5493.
Huffnagle, G.B., Yates, J.L., and Lipscomb, M.F. (1991a). Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J. Exp. Med. 173(4): 793–800.
Huffnagle, G.B., Yates, J.L, and Lipscomb, M.F. (1991b). T cell-mediated immunity in the lung: A Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect. Immun. 59(4): 1423–1433.
Huffnagle, G.B., Lipscomb, M.F., Lovchik, J.A., Hoag, K.A., and Street, N.E. (1994). The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukoc. Biol. 55(1): 35–42.
Huffnagle, G.B., Chen, G.H., Curtis, J.L., McDonald, R.A., Strieter, R.M., and Toews, G.B. (1995a). Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J. Immunol. 155(7): 3507–3516.
Huffnagle, G.B., Strieter, R.M., Standiford, T.J., McDonald, R.A., Burdick, M.D., Kunkel, S.L., and Toews, G.B. (1995b). The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol. 155(10): 4790–4797.
Huffnagle, G.B., Toews, G.B., Burdick, M.D., Boyd, M.B., McAllister, K.S., McDonald, R.A., Kunkel, S.L., and Strieter, R.M. (1996). Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol. 157(10): 4529–4536.
Huffnagle, G.B., Strieter, R.M., McNeil, L.K., McDonald, R.A., Burdick, M.D., Kunkel, S.L., and Toews, G.B. (1997). Macrophage inflammatory protein-1 alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J. Immunol. 159(1): 318–327.
Huffnagle, G.B., Boyd, M.B., Street, N.E., and Lipscomb, M.F. (1998). IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). J. Immunol. 160(5): 2393–2400.
Huffnagle, G.B., McNeil, L.K., McDonald, R.A., Murphy, J.W., Toews, G.B., Maeda, N., and Kuziel, W.A. (1999). Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J. Immunol. 163(9): 4642–4646.
Humphreys, I.R., Edwards, L., Walzl, G., Rae, A.J., Dougan, G., Hill, S., and Hussell, T. (2003). OX40 Ligation on activated T cells enhances the control of Cryptococcus neoformans and reduces pulmonary eosinophilia. J. Immunol. 170(12): 6125–6132.
Iezzi, G., Scheidegger, D., and Lanzavecchia, A. (2001). Migration and function of antigenprimed nonpolarized T lymphocytes in vivo. J. Exp. Med. 193(8): 987–993.
Kawakami, K., Tohyama, M., Teruya, K., Kudeken, N., Xie, Q., and Saito, A. (1996a). Contribution of interferon-gamma in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunol. Med. Microbiol. 13(2): 123–130.
Kawakami, K., Tohyama, M., Xie, Q., and Saito, A. (1996b). IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin. Exp. Immunol. 104(2): 208–214.
Kawakami, K., Qureshi, M.H., Zhang, T., Okamura, H., Kurimoto, M., and Saito, A. (1997). IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. J. Immunol. 159(11): 5528–5534.
Kawakami, K., Koguchi, Y., Qureshi, M.H., Kinjo, Y., Yara, S., Miyazato, A., Kurimoto, M., Takeda, K., Akira, S., and Saito, A. (2000). Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice. FEMS Microbiol. Lett. 186(1): 121–126.
Kawakami, K., Kinjo, Y., Uezu, K., Yara, S., Miyagi, K., Koguchi, Y., Nakayama, T., Taniguchi, M., and Saito, A. (2001a). Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J. Immunol. 167(11): 6525–6532.
Kawakami, K., Kinjo, Y., Yara, S., Koguchi, Y., Uezu, K., Nakayama, T., Taniguchi, M., and Saito, A. (2001b). Activation of Vα4+ natural killer T cells by α-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect. Immun. 69(1): 213–220.
Kurup, V.P. and Grunig, G. (2002). Animal models of allergic bronchopulmonary aspergillosis. Mycopathologia 153(4): 165–177.
Levitz, S.M. and Dupont, M.P. (1993). Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro. J. Clin. Invest. 91(4): 1490–1498.
Levitz, S.M., Dupont, M.P., and Smail, E.H. (1994). Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Infect. Immun. 62(1): 194–202.
Levitz, S.M., Nong, S., Mansour, M.K., Huang, C., and Specht, C.A. (2001). Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans. Proc. Natl. Acad. Sci. USA 98(18): 10422–10427.
Lim, T.S. and Murphy, J.W. (1980). Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice. Infect. Immun. 30(1): 5–11.
Lindell, D.M., G.B. Toews, R.A. McDonald and G.B. Huffnagle (2005a). Distinct Compartmentalization of CD4+ T Cell Effector function versus Proliferative Capacity During Pulmonary Cryptococcosis. Submitted for publication.
Lindell, D.M., G.B. Toews, R.A. McDonald and G.B. Huffnagle (2005b). Generation of Antifungal Effector CD8+ T cells in the Absence of CD4+ T cells During Cryptococcus neoformans Infection. Submitted for publication.
Lovchik, J.A., Lyons, C.R., and Lipscomb, M.F. (1995). A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am. J. Respir. Cell Mol. Biol. 13(1): 116–124.
Ma, L.L., Spurrell, J.C., Wang, J.F., Neely, G.G., Epelman, S., Krensky, A.M., and Mody, C.H. (2002). CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15. J. Immunol. 169(10): 5787–5795.
Mansour, M.K., Schlesinger, L.S., and Levitz, S.M. (2002). Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors. J. Immunol. 168(6): 2872–2879.
Mariano Andrade, R., Monteiro Almeida, G., Alexandre DosReis, G., and Alves Melo Bento, C. (2003). Glucuronoxylomannan of Cryptococcus neoformans exacerbates in vitro yeast cell growth by interleukin 10-dependent inhibition of CD4+ T lymphocyte responses. Cell. Immunol. 222(2): 116–125.
McGaha, T. and Murphy, J.W. (2000). CTLA-4 down-regulates the protective anticryptococcal cell-mediated immune response. Infect. Immun. 68(8): 4624–4630.
Mednick, A.J., Feldmesser, M., Rivera, J., and Casadevall, A. (2003). Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis. Eur. J. Immunol. 33(6): 1744–1753.
Mencacci, A., Del Sero, G., Cenci, E., d’Ostiani, C.F., Bacci, A., Montagnoli, C., Kopf, M., and Romani, L. (1998). Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans. J. Exp. Med. 187(3): 307–317.
Micallef, M.J., Ohtsuki, T., Kohno, K., Tanabe, F., Ushio, S., Namba, M., Tanimoto, T., Torigoe, K., Fujii, M., Ikeda, M., Fukuda, S., and Kurimoto, M. (1996). Interferon-gammainducing factor enhances T helper 1 cytokine production by stimulated human T cells: Synergism with interleukin-12 for interferongamma production. Eur. J. Immunol. 26(7): 1647–1651.
Miller, G.P. and Puck, J. (1984). In vitro human lymphocyte responses to Cryptococcus neoformans. Evidence for primary and secondary responses in normals and infected subjects. J. Immunol. 133(1): 166–172.
Mody, C.H., Lipscomb, M.F., Street, N.E., and Toews, G.B. (1990). Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J. Immunol. 144(4): 1472–1477.
Mody, C.H., Chen, G.H., Jackson, C., Curtis, J.L., and Toews, G.B. (1993a). Depletion of murine CD8+ T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans. J. Lab. Clin. Med. 121(6): 765–773.
Mody, C.H., Paine, R. III, Jackson, C.J., and Toews, G.B. (1993b). CD8 cells mediate delayed hypersensitivity following intrapulmonary infection with Cryptococcus neoformans. Chest 103(2 Suppl.): 118S.
Mody, C.H., Chen, G.H., Jackson, C., Curtis, J.L., and Toews, G.B. (1994). In vivo depletion of murine CD8 positive T cells impairs survival during infection with a highly virulent strain of Cryptococcus neoformans. Mycopathologia 125(1): 7–17.
Mody, C.H., Sims, K.L., Wood, C.J., Syme, R.M., Spurrell, J.C., and Sexton, M.M. (1996). Proteins in the cell wall and membrane of Cryptococcus neoformans stimulate lymphocytes from both adults and fetal cord blood to proliferate. Infect. Immun. 64(11): 4811–4819.
Mody, C.H., Wood, C.J., Syme, R.M., and Spurrell, J.C. (1999). The cell wall and membrane of Cryptococcus neoformans possess a mitogen for human T lymphocytes. Infect. Immun. 67(2): 936–941.
Munder, M., Eichmann, K., and Modolell, M. (1998). Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: Competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J. Immunol. 160(11): 5347–5354.
Murphy, J.W. and Pahlavan, N. (1979). Cryptococcal culture filtrate antigen for detection of delayed-type hypersensitivity in cryptococcosis. Infect. Immun. 25(1): 284–292.
Murphy, J.W., Hidore, M.R., and Wong, S.C. (1993). Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans. J. Clin. Invest. 91(4): 1553–1566.
Murphy, J.W., Schafer, F., Casadevall, A., and Adesina, A. (1998). Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans. Infect. Immun. 66(6): 2632–2639.
Muth, S.M. and Murphy, J.W. (1995). Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice. Infect. Immun. 63(5): 1637–1644.
Noverr, M.C., Phare, S.M., Toews, G.B., Coffey, M.J., and Huffnagle, G.B. (2001). Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect. Immun. 69(5): 2957–2963.
Noverr, M.C., Toews, G.B., and Huffnagle, G.B. (2002). Production of prostaglandins and leukotrienes by pathogenic fungi. Infect. Immun. 70(1): 400–402.
Noverr, M.C., Cox, G.M., Perfect, J.R., and Huffnagle, G.B. (2003a). Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect. Immun. 71(3): 1538–1547.
Noverr, M.C., Erb-Downward, J.R., and Huffnagle, G.B. (2003b). Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin. Microbiol. Rev. 16(3): 517–533.
Okamura, H., Tsutsi, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., and et al. (1995). Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378(6552): 88–91.
Okamura, H., Tsutsui, H., Kashiwamura, S., Yoshimoto, T., and Nakanishi, K. (1998). Interleukin-18: A novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70: 281–312.
Olszewski, M.A., Huffnagle, G.B., McDonald, R.A., Lindell, D.M., Moore, B.B., Cook, D.N., and Toews, G.B. (2000). The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. J. Immunol. 165(11): 6429–6436.
Olszewski, M.A., Huffnagle, G.B., Traynor, T.R., McDonald, R.A., Cook, D.N., and Toews, G.B. (2001). Regulatory effects of macrophage inflammatory protein 1α/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines. Infect. Immun. 69(10): 6256–6263.
Pietrella, D., Perito, S., Bistoni, F., and Vecchiarelli, A. (2001). Cytotoxic T lymphocyte antigen costimulation influences T-cell activation in response to Cryptococcus neoformans. Infect. Immun. 69(3): 1508–1514.
Pietrella, D., Mazzolla, R., Lupo, P., Pitzurra, L., Gomez, M.J., Cherniak, R., and Vecchiarelli, A. (2002). Mannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice. Infect. Immun. 70(12): 6621–6627.
Pitzurra, L., Cherniak, R., Giammarioli, M., Perito, S., Bistoni, F., and Vecchiarelli, A. (2000). Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins. Infect. Immun. 68(2): 558–563.
Qureshi, M.H., Zhang, T., Koguchi, Y., Nakashima, K., Okamura, H., Kurimoto, M., and Kawakami, K. (1999). Combined effects of IL-12 and IL-18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans. Eur. J. Immunol. 29(2): 643–649.
Retini, C., Casadevall, A., Pietrella, D., Monari, C., Palazzetti, B., and Vecchiarelli, A. (1999). Specific activated T cells regulate IL-12 production by human monocytes stimulated with Cryptococcus neoformans. J. Immunol. 162(3): 1618–1623.
Retini, C., Kozel, T.R., Pietrella, D., Monari, C., Bistoni, F., and Vecchiarelli, A. (2001). Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans. Infect. Immun. 69(10): 6064–6073.
Ricchetti, A., Landis, B.N., Maffioli, A., Giger, R., Zeng, C., and Lacroix, J.S. (2002). Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J. Laryngol. Otol. 116(4): 261–263.
Rivera, J., Mukherjee, J., Weiss, L.M., and Casadevall, A. (2002). Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: A role for nitric oxide. J. Immunol. 168(7): 3419–3427.
Roberts, C.W., Ferguson, D.J., Jebbari, H., Satoskar, A., Bluethmann, H., and Alexander, J. (1996). Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infect. Immun. 64(3): 897–904.
Salkowski, C.A. and Balish, E. (1990). Pathogenesis of Cryptococcus neoformans in congenitally immunodeficient beige athymic mice. Infect. Immun. 58(10): 3300–3306.
Schoenberger, S.P., Toes, R.E., van der Voort, E.I., Offringa, R., and Melief, C.J. (1998). T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393(6684): 480–483.
Segal, B.H., Bow, E.J., and Menichetti, F. (2002). Fungal infections in nontransplant patients with hematologic malignancies. Infect. Dis. Clin. North Am. 16(4): 935–964, vii.
Sergeeva, M.G., Gonchar, M.V., Mevkh, A.T., and Varfolomeyev, S.D. (1997). Prostaglandin E2 biphasic control of lymphocyte proliferation: Inhibition by picomolar concentrations. FEBS Lett. 418(3): 235–238.
Shedlock, D.J. and Shen, A. (2003). Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300(5617): 337–339.
Snijdewint, F.G., Kalinski, P., Wierenga, E.A., Bos, J.D., and Kapsenberg, M.L. (1993). Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150(12): 5321–5329.
Stein, M., Keshav, S., Harris, N., and Gordon, S. (1992). Interleukin 4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunologic macrophage activation. J. Exp. Med. 176(1): 287–292.
Steinman, R.M. (1996). Dendritic cells and immune-based therapies. Exp. Hematol. 24(8): 859–862.
Syme, R.M., Wood, C.J., Wong, H., and Mody, C.H. (1997). Both CD4+ and CD8+ human lymphocytes are activated and proliferate in response to Cryptococcus neoformans. Immunology 92(2): 194–200.
Syme, R.M., Bruno, T.F., Kozel, T.R., and Mody, C.H. (1999). The capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibody. Infect. Immun. 67(9): 4620–4627.
Syme, R.M., Spurrell, J.C., Ma, L.L., Green, F.H., and Mody, C.H. (2000). Phagocytosis and protein processing are required for presentation of Cryptococcus neoformans mitogen to T lymphocytes. Infect. Immun. 68(11): 6147–6153.
Syme, R.M., Spurrell, J.C.L., Amankwah, E.K., Green, F.H.Y., and Mody, C.H. (2002). Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcγ receptor II for presentation to T lymphocytes. Infect Immun. 70(11): 5972–5981.
Traynor, T.R. and Huffnagle, G.B. (2001). Role of chemokines in fungal infections. Med. Mycol. 39(1): 41–50.
Traynor, T.R., Kuziel, W.A., Toews, G.B., and Huffnagle, G.B. (2000). CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J. Immunol. 164(4): 2021–2027.
Traynor, T.R., Herring, A.C., Dorf, M.E., Kuziel, W.A., Toews, G.B., and Huffnagle, G.B. (2002). Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity. J. Immunol. 168(9): 4659–4666.
Vecchiarelli, A. (2000). Immunoregulation by capsular components of Cryptococcus neoformans. Med. Mycol. 38(6): 407–417.
Vecchiarelli, A., Monari, C., Retini, C., Pietrella, D., Palazzetti, B., Pitzurra, L., and Casadevall, A. (1998). Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes. Eur. J. Immunol. 28(1): 114–121.
Vecchiarelli, A., Pietrella, D., Lupo, P., Bistoni, F., McFadden, D.C., and Casadevall, A. (2003). The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation. J. Leukoc. Biol. 74(3): 370–378.
Venarske, D.L. and deShazo, R.D. (2002). Sinobronchial allergic mycosis: The SAM syndrome. Chest 121(5): 1670–1676.
Walunas, T.L., Lenschow, D.J., Bakker, C.Y., Linsley, P.S., Freeman, G.J., Green, J.M., Thompson, C.B., and Bluestone, J.A. (1994). CTLA-4 can function as a negative regulator of T cell activation. Immunity 1(5): 405–413.
Walzl, G., Humphreys, I.R., Marshall, B.G., Edwards, L., Openshaw, P.J.M., Shaw, R.J., and Hussell, T. (2003). Prior exposure to live Mycobacterium bovis BCG decreases Cryptococcus neoformans-induced lung eosinophilia in a gamma interferon-dependent manner. Infect. Immun. 71(6): 3384–3391.
Wuthrich, M., Filutowicz, H.I., Warner, T., Deepe, G.S. Jr., and Klein, B.S. (2003). Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: Implications for vaccine development in immune-deficient hosts. J. Exp. Med. 197(11): 1405–1416.
Yamazumi, T., Pfaller, M.A., Messer, S.A., Houston, A.K., Boyken, L., Hollis, R.J., Furuta, I., and Jones, R.N. (2003). Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans. J. Clin. Microbiol. 41(1): 267–272.
Yuan, R.R., Casadevall, A., Oh, J., and Scharff, M.D. (1997). T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc. Natl. Acad. Sci. USA 94(6): 2483–2488.
Yuan, R., Clynes, R., Oh, J., Ravetch, J.V., and Scharff, M.D. (1998a). Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. J. Exp. Med. 187(4): 641–648.
Yuan, R.R., Spira, G., Oh, J., Paizi, M., Casadevall, A., and Scharff, M.D. (1998b). Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice. Infect. Immun. 66(3): 1057–1062.
Zhang, T., Kawakami, K., Qureshi, M.H., Okamura, H., Kurimoto, M., and Saito, A. (1997). Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect. Immun. 65(9): 3594–3599.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Lindell, D.M., Huffnagle, G.B. (2005). Pulmonary Cell-Mediated Immunity (CMI) to Cryptococcus neoformans. In: Fidel, P.L., Huffnagle, G.B. (eds) Fungal Immunology. Springer, Boston, MA. https://doi.org/10.1007/0-387-25445-5_8
Download citation
DOI: https://doi.org/10.1007/0-387-25445-5_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-24092-3
Online ISBN: 978-0-387-25445-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)